National Research Corp(NRC)
Exchange:NASDAQ
Sector:Healthcare
Industry:
Health Information Services
Operation:
Domestic
IPO Date:
1997-10-10
Employees:
435
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Financial Ratios Overview (2023)
Current Ratio
0.67
Acid-Test Ratio
0.67
Cash Ratio
0.18
Operating Cash Flow Ratio
1.05
Debt Ratio
0.74
Interest Coverage Ratio
28.07
Debt Service Coverage Ratio
1.24
Asset Turnover Ratio
1.21
Inventory Turnover Ratio
Receivable Turnover Ratio
12.95
Days Sales in Inventory Ratio
Infinity days
Gross Margin Ratio
0.58
Operating Margin Ratio
0.27
Return on Assets Ratio
0.25
Return on Equity Ratio
0.63
Book Value per Share Ratio
0
Earnings per Share Ratio
-1.24
Histroric Financial Stats
We are finding ways to improve data quality all the time. Please report any data related issue to cliffgoslinginc@gmail.com.
20232022202120202019
Total Revenue
148.58 M
151.57 M
147.95 M
133.28 M
127.98 M
Cost of Revenue
-61.91 M
-57.05 M
-52.35 M
-49.19 M
-46.44 M
Gross Profit
86.67 M
94.52 M
95.6 M
84.09 M
81.55 M
Operating Expenses
-46.58 M
-47.98 M
-45.33 M
-41.95 M
-38.51 M
Total Expenses
-108.49 M
-105.03 M
-97.68 M
-91.13 M
-84.95 M
Operating Income
40.09 M
46.54 M
50.27 M
42.68 M
43.04 M
Total Other Income
-124 k
-3.73 M
-1.65 M
-1.21 M
-2.52 M
Pretax Income
39.96 M
42.82 M
48.62 M
41.47 M
40.52 M
Tax Provision
-9.21 M
-11.02 M
-11.16 M
-4.21 M
-8.11 M
Net Income Common Shareholders
0
31.8 M
37.47 M
37.26 M
32.41 M
EBIT
40.09 M
46.54 M
50.27 M
42.68 M
43.04 M
EBITDA
45.99 M
51.87 M
56.66 M
50.25 M
48.15 M
Reconciled Depreciation
-5.84 M
-5.28 M
-6.37 M
-7.51 M
-5.54 M
Common Stock Shares Outstanding
24.67 M
25.05 M
25.64 M
25.7 M
25.65 M
Diluted EPS
0
1.27
1.46
1.45
1.26
Minority Interest
0
0
0
0
0
Projected Return on Equity
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 29.51%
Curve fitting error: 0.0284
Projected Return on Assets
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 15.17%
Curve fitting error: 0.0054
@2025 by Times Arrow (cliffgoslinginc@gmail.com)